Explore how genetic ancestry influences individual responses to medications and environmental factors. The discussion emphasizes the importance of transitioning from population-based studies to personalized, n of one trials, allowing for tailored healthcare solutions that cater to unique patient needs, particularly in the context of heart disease.
